搜索临床试验以:degarelix antagonist protocol
总计40083个结果
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的疼痛 | 淋巴瘤 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 未明确的成人实体瘤,特定方案 | 神经毒性 | 多发性骨髓瘤和浆细胞肿瘤 | 淋巴增生性疾病 | 骨髓增生异常/骨髓增生性肿瘤美国
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology完全的
-
Rahul AggarwalSanofi完全的
-
Azienda Socio Sanitaria Territoriale degli Spedali...Ferring Pharmaceuticals未知
-
Postgraduate Institute of Medical Education and...终止
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)终止
-
University Hospital, EssenDeutsche Krebshilfe e.V., Bonn (Germany)完全的
-
University Hospital, Basel, SwitzerlandMerck Serono International SA完全的
-
Kaiser Franz Josef Hospital完全的
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)完全的
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)完全的
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)终止
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.终止
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的淋巴瘤 | 未明确的儿童实体瘤,具体方案 | 骨髓增生异常综合征 | 白血病 | 慢性骨髓增生性疾病 | 小肠癌 | 未明确的成人实体瘤,特定方案 | 多发性骨髓瘤和浆细胞肿瘤 | 癌前病变 | 恶心和呕吐美国
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的